Some young women may inadvertently notice cherry-sized “landmines” on their breasts, small bumps with a smooth surface that can be pushed and are painless. Most of these “mines” are benign tumors called breast fibroadenomas. Breast fibroadenoma occurs in women between the ages of 18 and 25, and although it is a benign tumor, it has the potential to become malignant. Most women do not pay attention to it before marriage, but after marriage, due to pregnancy, the progesterone and estrogen in the body increase, and the breast fibroadenoma also increases rapidly. Surgical treatment during pregnancy is easy to cause miscarriage, and postoperative drugs will also have a certain effect on the growth and development of the fetus. In addition, 10% of lobular breast cancers have symptoms similar to those of fibroadenomas, which will pose a challenge to life if treatment is delayed. Therefore, breast fibroadenoma should be treated as soon as possible. The Breast Department of the Third Affiliated Hospital of Zhengzhou University (i.e. Henan Provincial Breast Disease Prevention and Control Center) is a large-scale breast disease diagnosis and treatment center integrating clinical, scientific research, teaching and prevention. Using breast Mammotome minimally invasive surgery to treat breast fibroadenoma, the U.S. all-imported-Mammotome (MMT) is a newest treatment system that achieves diagnosis and treatment of breast lump disease through minimally invasive surgical non-surgical methods. It can remove the lesion with minimal loss, leaving no scar after the operation, minimizing trauma, quick recovery, and removing multiple lesions with a tiny eyelet, with excellent cosmetic effect. And it can biopsy the tiny suspicious lesions of breast with the help of ultrasound or molybdenum target, which is easy to find early breast cancer. It has successfully restored breast health for thousands of breast disease patients, maintained perfect curves and breast aesthetics, and has been favored by the majority of lady friends.